Aptevo Therapeutics Inc. (APVO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 15.98M | 23.08M | 22.65M | 11.08M | 3.61M | 10.66M | 10.01M | 9.58M | 12.07M | 19.07M | 21.13M | 22.68M |
| Cash & Short-Term Investments | 14.53M | 21.62M | 21.06M | 9.41M | 2.14M | 8.71M | 7.75M | 8.07M | 10.25M | 16.9M | 19.11M | 21.01M |
| Cash Only | 14.53M | 21.62M | 21.06M | 9.41M | 2.14M | 8.71M | 7.75M | 8.07M | 10.25M | 16.9M | 19.11M | 21.01M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.46M | 1.46M | 77K | 82K | 120K | 256K | 624K | 715K | 691K | 689K | 649K | 764K |
| Total Non-Current Assets | 3.92M | 4.11M | 4.35M | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.55M | 5.78M | 6M | 6.23M |
| Property, Plant & Equipment | 3.92M | 4.11M | 4.35M | 4.54M | 4.74M | 4.93M | 5.13M | 5.34M | 5.55M | 5.78M | 6M | 6.23M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 19.9M | 27.19M | 27M | 15.62M | 8.34M | 15.59M | 15.15M | 14.92M | 17.63M | 24.84M | 27.13M | 28.91M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 138.58% | 74.42% | 78.24% | 4.71% | -52.68% | -37.24% | -44.17% | -48.39% | -49.59% | -27.39% | -14.41% | -25.48% |
| Total Current Liabilities | 4.76M | 6.05M | 5.61M | 4.89M | 5.39M | 6.21M | 5.88M | 5.42M | 6.3M | 7.22M | 6.84M | 6.91M |
| Accounts Payable | 890K | 877K | 2.22M | 2.9M | 3.79M | 3.05M | 3.53M | 3.74M | 3.72M | 3.98M | 4M | 0 |
| Days Payables Outstanding | 2.27K | 1.76K | - | - | - | 4.27K | - | - | 3.31K | - | - | - |
| Short-Term Debt | 892K | 866K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.98M | 4.31M | 1.49M | 1.99M | 1.6M | 3.15M | 1.43M | 791K | 968K | 1.14M | 1.31M | 6.91M |
| Current Ratio | 3.36x | 3.82x | 4.03x | 2.27x | 0.67x | 1.72x | 1.70x | 1.77x | 1.92x | 2.64x | 3.09x | 3.28x |
| Quick Ratio | 3.36x | 3.82x | 4.03x | 2.27x | 0.67x | 1.72x | 1.70x | 1.77x | 1.92x | 2.64x | 3.09x | 3.28x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.53M | 3.76M | 3.99M | 4.21M | 4.42M | 4.63M | 4.84M | 5.04M | 5.23M | 5.4M | 5.58M | 5.75M |
| Long-Term Debt | 3.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 3.76M | 3.99M | 4.21M | 4.42M | 4.63M | 4.83M | 5.03M | 5.21M | 5.4M | 5.58M | 5.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 14K | 14K | 0 | 0 | 0 |
| Total Liabilities | 8.29M | 9.81M | 9.6M | 9.1M | 9.81M | 10.84M | 10.73M | 10.46M | 11.53M | 12.62M | 12.41M | 12.66M |
| Total Debt | 4.42M | 4.63M | 3.99M | 4.21M | 4.42M | 4.63M | 4.83M | 5.03M | 5.21M | 5.4M | 5.58M | 5.75M |
| Net Debt | -10.1M | -16.99M | -17.07M | -5.2M | 2.28M | -4.08M | -2.92M | -3.04M | -5.04M | -11.51M | -13.54M | -15.26M |
| Debt / Equity | 0.38x | 0.27x | 0.23x | 0.65x | - | 0.97x | 1.09x | 1.13x | 0.85x | 0.44x | 0.38x | 0.35x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 11.61M | 17.38M | 17.39M | 6.52M | -1.47M | 4.75M | 4.42M | 4.46M | 6.1M | 12.22M | 14.72M | 16.25M |
| Equity Growth % | 888.32% | 265.53% | 293.48% | 46.18% | -124.14% | -61.09% | -69.97% | -72.54% | -73.76% | -32.01% | -6.62% | -29.48% |
| Book Value per Share | 10.95 | 5509.03 | 77.32 | 159.09 | -363.61 | 1173.78 | 5581.32 | 16889.00 | 118374.57 | 367907.15 | 685739.53 | 999999.00 |
| Total Shareholders' Equity | 11.61M | 17.38M | 17.39M | 6.52M | -1.47M | 4.75M | 4.42M | 4.46M | 6.1M | 12.22M | 14.72M | 16.25M |
| Common Stock | 114K | 114K | 110K | 99K | 84K | 84K | 82K | 69K | 66K | 61K | 56K | 49K |
| Retained Earnings | -281.91M | -275.12M | -269.22M | -260.19M | -253.99M | -247.58M | -241.26M | -236.16M | -230.28M | -223.45M | -217.54M | -211.21M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |